−£6,941
vs Nov 2024Active15273310Private limited companyBorehamwood
NEWCLEIC LTD
E23/100From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
01
Summary
NEWCLEIC LTD is an active private limited company (company number 15273310) incorporated on 9 November 2023, registered in Borehamwood. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 November 2025, showing net assets of −£6,941, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 466% on the prior period (−£1,226).
Peer position · net assets
By net assets it sits in the bottom quarter of 151 comparable companies in Greater London (median £200, upper quartile £53k).
02
Key dates
- Incorporated
- 9 November 20232 yrs ago
- Next accounts due
- 30 August 2027in 312 days
- Confirmation statement due
- 23 November 2026in 32 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
04
Financials
Not reported
Not disclosed
0
vs Nov 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | −£6,941 | — | — | £9,505 | — | — | 0 |
| 30 November 2024 | −£1,226 | — | — | £1,226 | — | — | 0 |
Current ratio0.2Current liabilities exceed current assets
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
05
Firmoscan score
23 / 100 · grade E
| 50 | Starting scoreEvery scored company starts here |
| −15 | Negative net assetsNet assets £-6,941 at 2025-11-30 |
| −8 | Net assets falling-466.2% vs prior period |
| −8 | Current liabilities exceed current assetsCurrent ratio 0.2 |
| +4 | Past first filingsIncorporated 2023-11-09 |
| 23 | Score, grade E |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- Dr Beatrice Judith Melinek
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Next accounts duein 312 days
- Confirmation statement duein 32 days
- Accounts period endNet liabilities £6,941 · micro accounts
- Accounts period endNet liabilities £1,226 · micro accounts
- Incorporated
08
Similar companies in Greater London
- GENEPICARuislip, · inc. Nov 2023
- BIOME RX PHARMA LIMITEDTwickenham · inc. Nov 2023
- PROTEROS BIOSTRUCTURES (UK) LIMITEDKingston Upon Thames · inc. Nov 2023
- VERIXUS LABS LTDRadlett · inc. Oct 2023
- IXIA CLINICAL LIMITEDEnfield · inc. Oct 2023
- PAISHANG BIOTECHNOLOGY LTDUxbridge · inc. Oct 2023
All companies incorporated on 9 November 2023 · in Nov 2023.
09
Reminders for NEWCLEIC LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.